Integrated Testing for Blood Disorders
Integrated anemia and sickle cell disease test yields high sensitivity and accuracy
Olivia Gaskill | | Quick Read
Effective management of blood disorders – such as anemia and sickle cell disease (SCD) – depend on accurate and rapid diagnosis, but lack of affordable, accessible testing makes this difficult in developing countries. Existing diagnostic technology platforms can already detect SCD, but there’s always room for improvement.
Researchers from Case Western Reserve University recognized this opportunity and integrated an anemia test into the Gazelle platform. They then tested samples from 46 patients studied for anemia and SCD (1). The test yielded 100 percent sensitivity and over 92.3 percent specificity for anemia, and 100 percent accuracy for hemoglobin variants.
“The study from Case Western Reserve demonstrates that a software enhancement […] holds the potential to allow our current sickle cell disease test to also check for anemia, which could help clinicians and patients to optimize disease management through a single, low-cost test,” said Patti White (1), co-founder and CEO of Hemex Health.
Enjoy our FREE content!
Log in or register to gain full unlimited access to all content on the The Pathologist site. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine
- Hemex Health (2020). Available at: https://bit.ly/3mj6yrG.